Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Peter Y. Kim Image

      Peter Y. Kim, MD, FACC

      Department of Cardiology, Division of Internal Medicine

      About Dr. Peter Y. Kim

      I have been privileged to work as a Professor in the Department of Cardiology at The University of Texas MD Anderson Cancer Center.  I matriculated from a combined BS/MD program at Texas A&M University in 2004. After completing my residency at the Robert Wood Johnson University Hospital in New Brunswick and cardiology fellowship training at Cooper University Hospital in Camden, New Jersey, I joined MD Anderson in September of 2010.  I have enjoyed contributing to the growing field of Onco-Cardiology, quality improvement in health care, and serving the mission of MD Anderson to eliminate cancer.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Research Interests

      I am engaged in clinical research to investigate observed complications of cancer therapy through cardiac monitoring of cancer patients particularly in the realms of QT prolongation, ischemic heart disease, cardiomyopathy, and effects of novel anticancer agents such as immune checkpoint inhibitors.

      I have also collaborated with others in team science particularly supporting colleagues in investigational therapeutics clinical research. 

      Clinical Interests

      My clinical interests are in quality and process improvement in patient care, particularly in electrocardiography and cardiac monitoring for cancer patients. I serve as the Medical Director of ECG and Holter Monitoring as well as the medical director of Cardiac monitoring/telemetry. I monitor quality control metrics for electrocardiograms (ECG) and holter monitoring to establish consistency and accuracy of reporting.

      Education & Training

      Degree-Granting Education

      2004Texas A&M University, College Station, Texas, US, MD
      2002Texas A&M University, College Station, Texas, US, BS in Biomedical Science

      Postgraduate Training

      2008-2010Cardiology Externship, Cardiology, University Medical and Dental Schools of New Jersey and Cardiovascular Associates of Delaware Valley, Various, New Jersey
      2008-2009Hospital Extern, New Jersey Community Hospitals, Various, New Jersey
      2007-2010Clinical Fellowship, Cardiovascular, UMDNJ-Cooper University Hospital, Camden, New Jersey
      2004-2007Clinical Residency, Internal Medicine, UMDNJ-Robert Wood Johnson University Hospital, New Brunswick, New Jersey

      Licenses & Certifications

      2011Board of Echocardiography
      2011Texas Department of Public Safety
      2010Cardiovascular Disease
      2010Texas Medical Board
      2009Board of Nuclear Cardiology
      2007Drug Enforcement Administration Certificate
      2007American Board of Internal Medicine

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2022

      Assistant Professor, Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2016

      Other Professional Positions

      Interviewer, Baylor-MD Anderson Internal Medicine Residency, Houston, TX, 2015 - 2016

      Reviewer, American College of Cardiology Cardiosurve Panel, Houston, TX, 2013 - 2015

      Extramural Institutional Committee Activities

      Member, Clinical Faculty Review Committee - Promotions, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, Excellence in Safety Award for Promotion of Teamwork and Safety, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Alternate Member, Cardiopulmonary Resuscitation Subcommittee, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, Medical Practice Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2022

      Member, Executive Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2019 - 2022

      Chair, Acute & Critical Care Subcommittee, The University of Texas MD Anderson Cancer Center, 2019 - 2022

      Panel Representative, Faculty Appeals Panel Representative, The University of Texas MD Anderson Cancer Center, 2018 - Present

      Member, FPPE Oversight Review Panel Member, The University of Texas MD Anderson Cancer Center, 2017 - 2022

      Vice-Chair, Acute and Critical Care Subcommittee, The University of Texas MD Anderson Cancer Center, 2017 - 2022

      Founder and Chair, Faculty Effectiveness Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2024

      Member, Credentials Committee of the Medical Staff Member, The University of Texas MD Anderson Cancer Center, 2016 - Present

      Presenter, Utilization Review Subcommittee, The University of Texas MD Anderson Cancer Center, 2016 - 2016

      Member, Transfusion Subcommittee, The University of Texas MD Anderson Cancer Center, 2016 - 2016

      Panel Member, Clinical Research Committee 3, The University of Texas MD Anderson Cancer Center, 2013 - 2013

      Member, Acute Care Services Steering Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present

      Founder and Chair, Cardiac Monitoring Effectiveness, The University of Texas MD Anderson Cancer Center, 2012 - Present

      Member, Acute & Critical Care Subcommittee, The University of Texas MD Anderson Cancer Center, 2012 - Present

      Honors & Awards

      2012Clinical Safety and Effectiveness Program Graduate (Team Leader) Session 16, The University of Texas MD Anderson Cancer Center
      2010Chief Cardiology Fellow, Cooper University Hospital
      2004Medical Science Scholar, Texas A&M University
      1998 - 2003Medical Science Scholar, Texas A&M University
      1998 - 2002President's Endowed Scholarship, Texas A&M University
      1998National Merit Scholarship Recipient, Tenet Healthcare Corporation

      Professional Memberships

      Korean American Medical Association

      2025 - 2025

      Korean American Medical Association

      2018 - 2020

      Korean American Medical Association

      2017 - 2018

      Korean American Medical Association

      2016 - 2017

      Korean American Medical Association

      2014 - 2016

      Korean American Medical Association

      2012 - 2014

      Korean American Medical Association

      2012 - Present

      American College of Cardiology

      2008 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2025. Cardiac Dysrhythmias in Cancer Patients. Invited. Cardio-Oncology Nursing Education (CONE). Houston, Texas, US.
      2. 2023. A phase Ib study of endogenous T cell therapy using SLC45A2-specific CD8 T cells for patients with metastatic uveal melanoma. Poster. 2023 ASCO Annual Meeting. Houston, Texas, US.

      Regional Presentations

      1. 2025. How to Prevent Cardiovascular Disease. Invited. Senior Citizen's Education Program. Houston, TX, US.

      National Presentations

      1. 2025. Diagnosis and Management of QT Prolongation. Invited. 2nd Annual Dowd Foundation Center Cardio-Oncology at Atrium Health Sanger Heart & Vascular Institute. Charlotte, NC, US.
      2. 2023. Cardio-Oncology Protecting the Heart of Cancer Patients. Invited. the 26th Annual Oncology Symposium for the Healthcare Provider for the APAO. Denver, CO, US.
      3. 2023. Management of Atrial Fibrillation in Patients with Cancer. Invited. Cardio-Oncology Multidisciplinary Practice (COMP 2023) Conference. Houston, TX, US.
      4. 2022. ECG review for the Physician assistant continuing education (PACE) education seminar,. ECG review for the Physician assistant continuing education (PACE) education seminar,. Houston, TX, US.
      5. 2021. Updates in Cardiology: Electrocardiography and QT monitoring in oncology patients. Updates in Cardiology: Electrocardiography and QT monitoring in oncology patients. Houston, TX, US.
      6. 2020. Management of Cardiac Dysrhythmias in the Cancer Patient. Invited. Cardio-Oncology Multidisciplinary Practice (COMP) 2020. Houston, TX, US.
      7. 2019. Anticoagulants and Antiplatelets, Gastroenterology, Hepatology, and Nutrition (GHN), Educational Lecture Series. Gastroenterology, Hepatology, and Nutrition (GHN) Educational Lecture Series. Houston, TX, US.
      8. 2019. Updates in Cardiology: New 2019 Afib guidelines. Invited. Updates in Cardiology: New 2019 Afib guidelines. Houston, TX, US.
      9. 2019. IOTOX Presentation Cardiotoxicity of Immune Checkpoint Inhibitors. Invited. IOTOX Presentation Cardiotoxicity of Immune Checkpoint Inhibitors. Houston, TX, US.
      10. 2018. Updates on direct oral anticoagulants, Gastroenterology, Hepatology, and Nutrition (GHN) Educational Lecture Series. Invited. Gastroenterology, Hepatology, and Nutrition (GHN) Educational Lecture Series. Houston, TX, US.
      11. 2017. Direct oral anticoagulants, Gastroenterology, Hepatology, and Nutrition (GHN) Educational Lecture Series. Invited. Gastroenterology, Hepatology, and Nutrition (GHN) Educational Lecture Series. Houston, TX, US.
      12. 2017. Cardiac Dysrhythmias and QT prolongation Associated with Cancer Drugs. Invited. Heart Success Program. Houston, TX, US.
      13. 2016. Electrocardiographic Monitoring in a Cancer Hospital. Invited. 4th International Cancer & The Heart. Houston, US.
      14. 2015. QT Prolongation & Torsades de Pointes and Moderator of Bortezomib Medicated Sudden Cardiac Death. 1st International Onco-Cardiology Bootcamp. Houston, TX, US.
      15. 2014. QT Monitoring in Chemotherapy. Invited. 3rd International Cancer & The Heart. Houston, TX, US.
      16. 2012. QT Prolongation & Torsades de Pointes. Invited. 2nd International Cancer & The Heart. Houston, TX, US.

      International Presentations

      1. 2025. Case-Series with ICI Cardiotoxicities: How to Diagnose and Treat Them with Imaging Guidance. Invited. 59th Annual Scientific Meeting of the Korean Society of Echocardiography. Seoul, KR.
      2. 2020. Immunotherapy Mediated Cardiotoxicity (Keynote Speaker). Invited. 2020 Winter Symposium of Working Group on Cardio-Oncology of Korean Society of Cardiology. Seoul, KR.

      Formal Peers

      1. 2021. 2021 14th Annual Meeting of the Korean Medical Society of Oncology and 2021 International Conference. Invited. Seoul.
      2. 2020. 2020 Winter Symposium of Working Group on Cardio-Oncology of Korean Society of Cardiology. Invited. Seoul.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Koutroumpakis E, Mohamed ASR, Chaftari P, Rosenthal DI, Gujial d, Nutting C, Kim PY, Bassett R, Fuller CD, Mouhayar E. Longitudinal Changes in the Carotid Arteries of Head and Neck Cancer Patients Following Radiation Therapy: Results from a Prospective Serial Imaging Biomarker Characterization Study. Radiotherapy and Oncology 195, 2024. e-Pub 2024. PMID: 38467343.
      2. Monlezun, DJ, Badalamenti, A, Javaid, AI, Marmagkiolis, K, Honan, KA, Kim, JW, Patel, R, Akhanti, B, Halperin, DM, Dasari, NV, Koutroumpakis, E, Kim, P, Lopez-Mattei, J, Yusuf, SW, Cilingiroglu, M, Mamas, MA, Gregoric, ID, Yao, JC, Hassan, SA, Iliescu, C. Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the “forgotten pulmonic valve”. Frontiers in Cardiovascular Medicine 9, 2023. e-Pub 2023. PMID: 36843627.
      3. Ahmed T, Marmagkiolis K, Ploch M, Irizarry-Caro JA, Amatullah A, Desai S, Aziz MK, Yarrabothula A, Fossas-Espinosa J, Koutroumpakis E, Hassan S, Karimzad K, Kim P, Cilingiroglu M, Iliescu C. The year in Cardio-oncology 2022. Curr Probl Cardiol 48(1):101435, 2023. e-Pub 2022. PMID: 36183977.
      4. Kim JW, Monlezun D, Park JK, Chauhan S, Balanescu D, Koutroumpakis E, Palaskas N, Kim P, Hassan S, Botz G, Crommett J, Reddy D, Cilingiroglu M, Marmagkiolis K, Iliescu C. Post-cardiac arrest PCI is underutilized among cancer patients: Machine learning augmented nationally representative case-control study of 30 million hospitalizations. Resuscitation 179:43-49, 2022. e-Pub 2022. PMID: 35933056.
      5. Kim JW, Dayah TJ, Javaid A, Monlezun DJ, Balanescu DV, Donisan T, Karimzad K, Hakeem A, Boone DL, Palaskas N, Lopez-Mattei J, Kim PY, Durand JB, Song J, Balanescu SM, Yang EH, Herrmann J, Marmagkiolis K, Toutouzas K, Johnson NP, Iliescu CA. Reclassification of Treatment Strategy with Fractional Flow Reserve in Cancer Patients with Coronary Artery Disease. Medicina (Kaunas) 58(7), 2022. e-Pub 2022. PMID: 35888603.
      6. Chauhan, S, Monlezun, DJ, Kim, JW, Goel, H, Hanna, A, Hoang, K, Palaskas, NL, Lopez-Mattei, J, Hassan, SA, Kim, P, Cilingiroglu, M, Marmagkiolis, K, Iliescu, C. Fractional Flow Reserve Cardio-Oncology Effects on Inpatient Mortality, Length of Stay, and Cost Based on Malignancy Type. Medicina (Lithuania) 58(7), 2022. e-Pub 2022. PMID: 35888578.
      7. Lin SH, Lin HY, Verma V, Xu-Welliver M, Thall PF, Yao L, Kim PY, Gombos DS, Kawedia JD, Komaki R, Gomez DR, Nguyen QN, O'Reilly MS, Lu C, Fossella FV, Skoulidis F, Zhang J, Tsao AS, Heymach JV, Blumenschein GR. Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer. Cancer Treat Res Commun 30:100514, 2022. e-Pub 2022. PMID: 35051703.
      8. Safdar A, Ahmed T, Liu VY, Addoumieh A, Agha AM, Giza DE, Balanescu DV, Donisan T, Dayah T, Lopez-Mattei JC, Kim PY, Hassan S, Karimzad K, Palaskas N, Tsai JY, Iliescu GD, Yang EH, Herrmann J, Marmagkiolis K, Angelini P, Iliescu CA. Trigger related outcomes of takotsubo syndrome in a cancer population. Front Cardiovasc Med 9:1019284, 2022. e-Pub 2022. PMID: 36386379.
      9. Ahmed T, Mouhayar E, Song J, Koutroumpakis E, Palaskas NL, Yusuf SW, Lopez-Mattei J, Hassan SA, Kim P, Cilingiroglu M, Marmagkiolis K, Vaporciyan AA, Swisher S, Deswal A, Iliescu C. Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis. Front Cardiovasc Med 9:916325, 2022. e-Pub 2022. PMID: 35711368.
      10. Javaid, AI, Monlezun, DJ, Iliescu, G, Tran, P, Filipescu, A, Palaskas, NL, Lopez-Mattei, J, Hassan, SA, Kim, P, Madjid, M, Cilingiroglu, M, Charitakis, K, Marmagkiolis, K, Iliescu, C, Koutroumpakis, E. Stress cardiomyopathy in hospitalized patients with cancer. ESC Heart Failure 8(6):4626-4634, 2021. e-Pub 2021. PMID: 34612022.
      11. Jacob, R, Palaskas, NL, Lopez-Mattei, J, Hassan, SA, Kim, P, Donisan, T, Balanescu, DV, Cilingiroglu, M, Marmagkiolis, K, Iliescu, C. How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia. JACC: CardioOncology 3(3):452-456, 2021. e-Pub 2021. PMID: 34604808.
      12. Pushparaji B, Donisan T, Balanescu DV, Palaskas N, Kim P, Lopez-Mattei J, Cilingiroglu M, Hassan SA, Boudoulas KD, Marmagkiolis K, Hajjar LA, Iliescu CA. Interventional Strategies in Cancer-induced Cardiovascular Disease. Curr Oncol Rep 23(11):133, 2021. e-Pub 2021. PMID: 34570291.
      13. Zarifa A, Kim JW, Lopez-Mattei J, Palaskas N, Iliescu C, Kim PY. Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management. Korean Circ J 51(7):579-597, 2021. e-Pub 2021. PMID: 34227272.
      14. Balanescu DV, Aziz MK, Donisan T, Palaskas N, Lopez-Mattei J, Hassan S, Kim P, Song J, Ntim W, Cilingiroglu M, Marmagkiolis K, Iliescu C. Cancer treatment resumption in patients with new-generation drug-eluting stents. Coron Artery Dis 32(4):295-301, 2021. e-Pub 2021. PMID: 33196581.
      15. Gill C, Lee M, Balanescu DV, Donisan T, Serauto Canache AJ, Palaskas N, Lopez-Mattei J, Kim PY, Song J, Yang EH, Cilingiroglu M, Kar B, Gregoric I, Marmagkiolis K, Iakobishvili Z, Iliescu C. Transcatheter and Surgical Aortic Valve Replacement Impact on Outcomes and Cancer Treatment Schedule. Int J Cardiol 326:62-70, 2021. e-Pub 2021. PMID: 32858137.
      16. Thomason, N, Monlezun, DJ, Javaid, AI, Filipescu, A, Koutroumpakis, E, Shobayo, F, Kim, P, Lopez-Mattei, J, Cilingiroglu, M, Iliescu, G, Marmagkiolis, K, Ramirez, PT, Iliescu, C. Percutaneous Coronary Intervention in Patients With Gynecological Cancer. Frontiers in Cardiovascular Medicine 8, 2021. e-Pub 2021. PMID: 35237670.
      17. Kim P, Masha L, Olson A, Iliescu C, Karimzad K, Hassan S, Palaskas N, Durand JB, Leung CH, Lopez-Mattei J. QT Prolongation in Cancer Patients. Front Cardiovasc Med 8:45, 2021. e-Pub 2021. PMID: 33718445.
      18. Agha AM, Palaskas N, Patel AR, DeCara J, Parwani P, Iliescu C, Durand JB, Kim P, Hassan S, Gladish G, Lee HC, Kaufman GP, Lopez-Mattei JC. Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis. Front Cardiovasc Med 8:496, 2021. e-Pub 2021. PMID: 34268341.
      19. Heidari-Bateni G, Durand JB, Iliescu C, Gladish G, Deswal A, Patel AR, Kim P, Song J, Hassan S, Palaskas N, Baldassarre LA, Bucciarelli-Ducci C, Lopez-Mattei J. Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected Cardiomyopathy. Front Cardiovasc Med 8:734820, 2021. e-Pub 2021. PMID: 34765654.
      20. Bravo-Jaimes K, Marcellon R, Varanitskaya L, Kim PY, Iliescu C, Gilchrist SC, Baldassarre LA, Manisty C, Ghosh AK, Guha A, Lopez-Mattei JC. Opportunities for improved cardiovascular disease prevention in oncology patients. Curr Opin Cardiol 35(5):531-537, 2020. e-Pub 2020. PMID: 32649353.
      21. Balanescu DV, Donisan T, Deswal A, Palaskas N, Song J, Lopez-Mattei J, Kim PY, Durand JB, Doundoua D, Marmagkiolis K, Iliescu C. Acute myocardial infarction in a high-risk cancer population: Outcomes following conservative versus invasive management. Int J Cardiol 313:1-8, 2020. e-Pub 2020. PMID: 32320781.
      22. Balanescu DV, Donisan T, Palaskas N, Lopez-Mattei J, Kim PY, Buja LM, McNamara DM, Kobashigawa JA, Durand JB, Iliescu CA. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy. Cardiovasc Pathol 47:107211, 2020. e-Pub 2020. PMID: 32268262.
      23. Pushparaji B, Marmagkiolis K, Miller C, Aziz M, Balanescu D, Donisan T, Palaskas N, Kim P, Lopez-Mattei J, Cilingiroglu M, Hassan S, Iliescu C. State-of-the-art Review: Interventional Onco-Cardiology. Current Treatment Options in Cardiovascular Medicine 22(5):1-24, 2020. e-Pub 2020.
      24. Mohamed MO, Lopez-Mattei JC, Parwani P, Iliescu CA, Bharadwaj A, Kim PY, Palaskas NL, Rashid M, Potts J, Kwok CS, Gulati M, Al Zubaidi AMB, Mamas MA. Management strategies and clinical outcomes of acute myocardial infarction in leukaemia patients: Nationwide insights from United States hospitalisations. Int J Clin Pract 74(5):e13476, 2020. e-Pub 2020. PMID: 31922635.
      25. Lopez-Mattei J, Verstovsek S, Fellman B, Iliescu C, Bhatti K, Hassan SA, Kim P, Gray BA, Palaskas NL, Grosu HB, Mamas MA, Faiz SA. Prevalence of pulmonary hypertension in myelofibrosis. Ann Hematol 99(4):781-789, 2020. e-Pub 2020. PMID: 32076825.
      26. Simbaqueba Clavijo, CA, Aponte, MP, Kim, P, Deswal, A, Palaskas, NL, Iliescu, C, Jahangir, E, Yang, EH, Steiner, RE, Lopez-Mattei, J. Cardiovascular complications of chimeric antigen receptor t-cell therapy. Journal of Immunotherapy and Precision Oncology 3(3):113-120, 2020. e-Pub 2020. PMID: 35663258.
      27. Parwani P, Co M, Ramesh T, Akhter N, Iliescu C, Palaskas N, Kim P, Gladish G, Stojanovska J, Abramov D, Lopez J. Differentiation of Cardiac Masses by Cardiac Magnetic Resonance Imaging. Current Cardiovascular Image Report 13(1), 2020. e-Pub 2020.
      28. Agha AM, Gill C, Balanescu DV, Donisan T, Palaskas N, Lopez-Mattei J, Hassan S, Kim PY, Charitakis K, Cilingiroglu M, Oo TH, Kroll M, Durand JB, Hirsch-Ginsberg C, Marmagkiolis K, Iliescu C. Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography. Front Cardiovasc Med 7:9, 2020. e-Pub 2020. PMID: 32118047.
      29. Zarifa A, Lopez-Mattei J, Palaskas N, Iliescu C, Durand JB, Kim PY. Immune Checkpoint Inhibitors (ICIs)-Related Cardiotoxicity. Adv Exp Med Biol 1244:277-285, 2020. e-Pub 2020. PMID: 32301022.
      30. Donisan T, Balanescu DV, Palaskas N, Lopez-Mattei J, Karimzad K, Kim P, Charitakis K, Cilingiroglu M, Marmagkiolis K, Iliescu C. Cardiac Interventional Procedures in Cardio-Oncology Patients. Cardiol Clin 37(4):469-486, 2019. e-Pub 2019. PMID: 31587788.
      31. Agha, A, Zarifa, A, Kim, P, Iliescu, C, Gladish, G, Hassan, SA, Palaskas, NL, Durand, J, Lu, Y, Lopez-Mattei, J. The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics. Methodist DeBakey cardiovascular journal 15(4):258-266, 2019. e-Pub 2019. PMID: 31988686.
      32. Borovac JA, Kwok CS, Iliescu C, Lee HJ, Kim PY, Palaskas NL, Zaman A, Butler R, Lopez-Mattei JC, Mamas MA. Percutaneous Coronary Intervention and Outcomes in Patients With Lymphoma in the United States (Nationwide Inpatient Sample [NIS] Analysis). Am J Cardiol 124(8):1190-1197, 2019. e-Pub 2019. PMID: 31395298.
      33. Sudasena D, Balanescu DV, Donisan T, Hassan S, Palaskas N, Kim P, Karimzad K, Lopez-Mattei J, Arain S, Gould KL, Iliescu C. Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib. Cardiovasc Toxicol 19(4):382-387, 2019. e-Pub 2019. PMID: 30543051.
      34. Balanescu SM, Balanescu DV, Donisan T, Yang EH, Palaskas N, Lopez-Mattei J, Hassan S, Kim P, Cilingiroglu M, Marmagkiolis K, Kar B, Iliescu C. The Onco-cardiologist Dilemma: to Implant, to Defer, or to Avoid Transcatheter Aortic Valve Replacement in Cancer Patients with Aortic Stenosis?. Curr Cardiol Rep 21(8):83, 2019. e-Pub 2019. PMID: 31286273.
      35. Zarifa, A, Albittar, A, Kim, P, Hassan, SA, Palaskas, NL, Iliescu, C, Durand, J, Lopez-Mattei, J. Cardiac toxicities of anticancer treatments. Current opinion in cardiology 34(4):441-450, 2019. e-Pub 2019. PMID: 31082852.
      36. Balanescu DV, Donisan T, Dayah T, Palaskas N, Lopez-Mattei J, Kim P, Pinnix CC, Moudgil R, Balanescu SM, Herrmann J, Cilingiroglu M, Marmagkiolis K, Iliescu C. Refractory radiation-induced coronary artery disease: mapping the path and guiding treatment with optical coherence tomography. Int J Cardiovasc Imaging 35(5):759-760, 2019. e-Pub 2019. PMID: 30758691.
      37. Balanescu DV, Donisan T, Lopez-Mattei J, Hassan S, Kim P, Dasari A, Halperin D, Yao J, Kar B, Gregoric I, Balanescu SM, Iliescu C. The 1, 2, 3, 4 of carcinoid heart disease: Comprehensive cardiovascular imaging is the mainstay of complex surgical treatment. Oncol Lett 17(5):4126-4132, 2019. e-Pub 2019. PMID: 30944605.
      38. Palaskas N, Morgan J, Daigle T, Banchs J, Durand JB, Hong D, Naing A, Le H, Hassan SA, Karimzad K, Mouhayar E, Kim P, Lopez-Mattei J, Thompson K, Yusuf SW, Iliescu C. Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol 123(8):1351-1357, 2019. e-Pub 2019. PMID: 30765065.
      39. Ghotra AS, Thompson K, Lopez-Mattei J, Bawa D, Hernandez R, Banchs J, Palaskas N, Iliescu C, Kim P, Yusuf SW, Hassan SA. Cardiovascular manifestations of Erdheim-Chester disease. Echocardiography 36(2):229-236, 2019. e-Pub 2019. PMID: 30569522.
      40. Balanescu DV, Monlezun DJ, Donisan T, Boone D, Cervoni-Curet F, Palaskas N, Lopez-Mattei J, Kim P, Iliescu C, Balanescu SM. A cancer paradox: machine learning-backed propensity score analysis of coronary angiography findings in cardio-oncology. J Invasive Cardiol 31(1), 2019. e-Pub 2019. PMID: 30611123.
      41. Agha AM, Lopez-Mattei J, Donisan T, Balanescu D, Iliescu CA, Banchs J, Kim PY, Palaskas NL, Yusuf S, Gladish G, Hassan S. Multimodality imaging in carcinoid heart disease. Open Heart 6(1):e001060, 2019. e-Pub 2019. PMID: 31245014.
      42. T Donisan T, D Balanescu D, G Iliescu G, J Mopez J, N Palaskas N, P Kim P, JB Durand JB, S Balanescu S, K Marmagkiolis K, C Iliescu C. Acute drops in ejection fraction in contemporary cardio-oncology: old diagnosis, new offenders. Romanian Journal of Cardiology 29(2):246-250, 2019. e-Pub 2019.
      43. Iliescu C, Balanescu DV, Donisan T, Giza DE, Muñoz Gonzalez ED, Cilingiroglu M, Song J, Mukerji SS, Lopez-Mattei JC, Kim PY, Palaskas N, Mouhayar EN, Durand JB, Marmagkiolis K. Safety of Diagnostic and Therapeutic Cardiac Catheterization in Cancer Patients with Acute Coronary Syndrome and Chronic Thrombocytopenia. Am J Cardiol 122(9):1465-1470, 2018. e-Pub 2018. PMID: 30180958.
      44. Varghese B, Ting K, Lopez-Mattei J, Iliescu C, Kim J, Kim P. Aspergillus endocarditis of the mitral valve with ventricular myocardial invasion, cerebral vasculitis, and intracranial mycotic aneurysm formation in a patient with hemophagocytic lymphohistiocytosis. Med Mycol Case Rep 21:49-51, 2018. e-Pub 2018. PMID: 29755935.
      45. Zarifa A, Salih M, Lopez J, Lee H, Iliescu C, Hassan S, Palaskas N, Durand JB, Mouhayar E, Kim J, Kim P. Cardiotoxicity of FDA-approved immune checkpoint inhibitors: A rare but serious adverse event. Journal of Immunotherapy and Precision Oncology, 2018. e-Pub 2018.
      46. Donisan T, Balanescu DV, Lopez-Mattei JC, Kim P, Leja MJ, Banchs J, Marmagkiolis K, Herrmann J, Gregoric I, Durand JB, Iliescu CA. In Search of a Less Invasive Approach to Cardiac Tumor Diagnosis Multimodality Imaging Assessment and Biopsy. JACC Cardiovasc Imaging 11(8):1191-5, 2018. e-Pub 2018. PMID: 30092973.
      47. Palaskas N, Thompson K, Gladish G, Agha AM, Hassan S, Iliescu C, Kim P, Durand JB, Lopez-Mattei JC. Evaluation and Management of Cardiac Tumors. Curr Treat Options Cardiovasc Med 20(4):29, 2018. e-Pub 2018. PMID: 29556752.
      48. Hassan SA, Palaskas N, Kim P, Iliescu C, Lopez-Mattei J, Mouhayar E, Mougdil R, Thompson K, Banchs J, Yusuf SW. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis. Curr Atheroscler Rep 20(2):10, 2018. e-Pub 2018. PMID: 29423705.
      49. Liu VY, Agha AM, Lopez-Mattei J, Palaskas N, Kim P, Thompson K, Mouhayar E, Marmagkiolis K, Hassan SA, Karimzad K, Iliescu CA. Interventional Cardio-Oncology:Adding a New Dimension to the Cardio-Oncology Field. Front Cardiovasc Med 5(48):48, 2018. e-Pub 2018. PMID: 29868614.
      50. Agha AM, Parwani P, Guha A, Durand JB, Iliescu CA, Hassan S, Palaskas NL, Gladish G, Kim PY, Lopez-Mattei J. Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open Heart 5(2):e000881, 2018. e-Pub 2018. PMID: 30305910.
      51. Giza DE, Lopez-Mattei J, Vejpongsa P, Munoz E, Iliescu G, Kitkungvan D, Hassan SA, Kim P, Ewer MS, Iliescu C. Stress-Induced Cardiomyopathy in Cancer Patients. Am J Cardiol 120(12):2284-2288, 2017. e-Pub 2017. PMID: 29096885.
      52. Giza D, Moudgil R, Lopez J, Kim P, Iliescu C. Association between ibrutinib and mid-cavitary Takotsubo cardiomyopathy: a case report and a review of chemotherapy-induced Takostubo’s cardiomyopathy. European Society of Cardiology 1(2):1-7, 2017. e-Pub 2017.
      53. Lopez-Mattei J, Iliescu C, Durand JB, Hassan S, Kim P, Sierra-Galan L, Gladish G. The role of cardiac MRI in cardio-oncology. Future Cardiol 13(4):311-316, 2017. e-Pub 2017. PMID: 28639454.
      54. Giza DE, Boccalandro F, Lopez-Mattei J, Iliescu G, Karimzad K, Kim P, Iliescu C. Ischemic Heart Disease: Special Considerations in Cardio-Oncology. Curr Treat Options Cardiovasc Med 19(37):37, 2017. e-Pub 2017. PMID: 28425056.
      55. Lee HJ, Chihara D, Wang M, Mouhayar E, Kim P. Ibrutinib Related Atrial Fibrillation in Patients with Mantle Cell Lymphoma. Leuk Lymphoma 57(12):1-3, 2016. e-Pub 2016. PMID: 27087288.
      56. Kim, P, Ewer, MS. Chemotherapy and QT prolongation. Current Treatment Options in Cardiovascular Medicine 16(5), 2014. e-Pub 2014. PMID: 24733423.
      57. Mouhayar E, Aoun R, Kim P, Iliescu C. Etiology of acute limb ischemia in cancer patients. Vascular Medicine 18(3):157-158, 2013. e-Pub 2013.
      58. Yusuf, SW, Kim, P, Durand, J. Erlotinib or gefitinib for non-small-cell lung cancer [1]. New England Journal of Medicine 364(24):2367-2368, 2011. e-Pub 2011. PMID: 21675910.
      59. Kim PY, Mendoza K, Kim JH, Moreno S, Casso-Chapa B, Beinart N, Paniagua-Borjorges A, Carrion A, Deswal A, Palaskas N, Koutroumpakis E, Abe J, Ewer E. QT Monitoring in Chemotherapy. Frontiers in Cardiovascular Medicine.

      Invited Articles

      1. Kim PY, Irizarry-Caro JA, Ramesh T, Iliescu C, Lopez-Mattei JC. How to Diagnose and Manage QT Prolongation in Cancer Patients. JACC CardioOncol 3(1):145-149, 2021. e-Pub 2021. PMID: 34396315.
      2. Kim P, Ewer M. Chemotherapy and QT prolongation: Overview with Clinical Perspective. Current Treatment Options in Cardiovascular Medicine 16(5):303, 2014. e-Pub 2014.

      Review Articles

      1. Kim, P, Ostos-Mendoza, KC, Kim, JH, López Moreno, SF, Casso-Chapa, B, Beinart, N, Paniagua Bojorges, A, Ruesta Carrion, A, Lenz, SA, Yusuf, SW, Deswal, A, Palaskas, NL, Koutroumpakis, E, Abe, J, Ewer, MS. QT monitoring in chemotherapy. Frontiers in Cardiovascular Medicine 13, 2026. e-Pub 2026. PMID: 42238267.

      Professional Educational Materials

      1. Kim P. QT Monitoring During Chemotherapy. The MD Anderson Practice (MAP), Ed(s) Yeh H, 2016.

      Other Articles

      1. Schechter, M, Balanescu, DV, Donisan, T, Dayah, TJ, Kar, B, Gregoric, ID, Giza, DE, Song, J, Lopez-Mattei, J, Kim, P, Balanescu, SM, Cilingiroglu, M, Toutouzas, KP, Smalling, R, Marmagkiolis, K, Iliescu, C An update on the management and outcomes of cancer patients with severe aortic stenosis. Catheterization and Cardiovascular Interventions 94(3):438-445, 2019. PMID: 30549397.

      Editorials

      1. Lopez-Mattei J, Kim P, Iliescu C. Editorial commentary: Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities. Trends Cardiovasc Med 29(1):40, 2019. PMID: 29958808.

      Abstracts

      1. Phillips S, Singh S, Lizee G, Solis LM, Welsh JW, Bassett RL, Beal LG, Kim PY, Murthy R, Talukder A, Lai I, Yee C, Patel SP. A phase Ib study of endogenous T cell therapy using SLC45A2-specific CD8 T cells for patients with metastatic uveal melanoma. ASCO, 2023. e-Pub 2023.
      2. Ahmed T, Safdar A, Song J, Banchs J, Kim PY, Palaskas N, Iliescu C. Abstract 12836: Predictors of Recurrent Pericardial Effusion in Cancer Patients Requiring Pericardiocentesis, 2021. e-Pub 2021.
      3. Azia M, Balanescu D, Donisan T, Pushparaji B, Hust M, Ganim N, graham J, Hoyt T, Lin H, Tomakin G, Ntim W, Palaskas, Lopez-Mattei J, Kim P, Cilingiroglu M, Marmagkiolis K, Deswal A, Feldman M, Molony D, Iliescu C. Vascular Healing in Cancer Patients with Drug-Eluting Stents: An Optical Coherence Tomography Comparison to the Non-Cancer Population. 2020 Scientific Sessions, 2020. e-Pub 2020.
      4. Hust M, Aziz M, d B, Donisan T, Pushparaji B, Hoyt T, Lin H, Graham J, Ganim N, Kim P, Lopez Mattei J, Marmagkiolis K, Cilingiroglu M, Feldman M, Molony D, Iliescu C. Optical Coherence Tomography for the Assessment of Drug-Eluting Stent Healing in Radiation-Induced Coronary Artery Disease. 2020 Scientific Sessions, 2020. e-Pub 2020.
      5. Donisan T, Balanescu D, Aziz M, Song J, Ntim W, Palaskas N, Lopez-Mattei J, Kim P, Cilingiroglu M, Marmagkiolis K, Deswal A, Iliescu C. Early Resumption Of Cancer Treatment After Percutaneous Coronary Intervention: Impact On Cardiovascular Outcomes. Journal of the American College of Cardiology 75(11 supplement 1):1407-1407, 2020. e-Pub 2020.
      6. Aziz M, Balanescu D, Donisan T, Song J, Palaskas N, Lopez-Mattei J, Kim P, Cilingiroglu M, Hermann J, Marmagkiolis K, Deswal A, Iliescu C. Intracoronary Imaging-Guided Discontinuation Of Dual Antiplatelet Therapy In Stented Patients Requiring Expedited Cancer Treatment. Journal of the American College of Cardiology 75(11 supplement 1):1408-1408, 2020. e-Pub 2020.
      7. Monlezun D, Gaiba R, Marmagkiolis K, Cilingiroglu M, Lopez-Mattei J, Kim P, Chauhan S, Hoang K, Folvi M, Hostetter L, Lee S, Yalamanchi A, Tamil M, Chen J, Thannoun T, Grable C, Chen N, Thomason N, Okirie V, Palaskas N, Colen J, DeSnyder S, Iliescu C. Pci Provides Costly Mortality Reductions For Breast Cancer Patients: Propensity Score And Machine Learning Augmented Nationally Representative Case-Control Study Of 30 Million+ …. Journal of the American College of Cardiology 75(11 supplement 1):3625-3625, 2020. e-Pub 2020.
      8. Serauto A, Lee M, Lopez-Mattei J, Gill C, Donisan T, Balanescu D, Marmagkiolis K, Palaskas N, Kim P, Deswal A, Iliescu C. Hematological Malignancies With Thrombocytopenia Undergoing Primary Percutaneous Pericardiocentesis: Periprocedural (30-Day) Overall Survival Analysis. Journal of the American College of Cardiology 75(11 supplement 1):1510-1510, 2020. e-Pub 2020.
      9. Monlezun D, Folivi M, Palaskas N, Lopez-Mattei J, Kim P, Chauhan S, Hoang K, Gaiba R, Hostetter L, Yalamanchi A, Tamil M, Chen J, Thannoun T, Grable C, Chen N, Thomason N, Boone D, Okirie V, Lee S, You N, Rodriguez-Bigas M, Iliescu C. CRT-101.02 PCI Provides Costly Mortality Reductions for Colon Cancer Patients: Propensity Score and Machine Learning Supported Nationally Representative Case-Control Study of …. Cardiovascular Interventions 13(4 Supplement S):S28-S28, 2020. e-Pub 2020.
      10. Mohamed MO, Lopez-Mattei JC, Parwani P, Iliescu CA, Bharadwaj A, Kim PY, Palaskas NL, Rashid M, Potts J, Kwok CS, Gulati M, Al Zubaidi AMB, Mamas MA. Management strategies and clinical outcomes of acute myocardial infarction in leukaemia patients: Nationwide insights from United States hospitalisations. Int J Clin Pract 74(5):e13476, 2020. e-Pub 2020. PMID: 31922635.
      11. Hostetter L, d M, Thannoun T, Pabba K, Lawless SM, Pate R, Grable C, d Z, Chen N, Palaskas N, Lopez-Maei J, Kim P, Cilingiroglu M, Marmagkiolis K, Iliescu C. Transcatheter Aortic Valve Replacement Reduces Inpatient Costs and Length of Stay for Cancer Patients With Severe Aortic Stenosis. Circulation 140(Suppl 1):A4614-A14614, 2019. e-Pub 2019.
      12. Bateni GH, Durand JB, Iliescu C, Mouhayar E, Palaskas NL, Chohan J, Sudasena D, Hassan S, Kim P, Parwani P, Jazayeri MA, Lopez-Mattei J. Cardiac Magnetic Resonance Clinical Impact in Management of Cardiomyopathy in a Cancer Center. Circulation 140(Suppl 1):A15308-A15308, 2019. e-Pub 2019.
      13. Balanescu DV, Donisan T, Lee M, Tran P, De Sirkar S, Palaskas N, Lopez-Mattei J, Kim PY, Iliescu G, Balanescu SM, Marmagkiolis K, Iliescu C. P3629 Invasive versus medical management of non-ST elevation myocardial infarction in cancer patients: knowledge is bliss. European Heart Journal 40(Suppl 1):ehz745.0487, 2019. e-Pub 2019.
      14. Mohamed MO, Lopez-Mattei JC, Iliescu CA, Purwani P, Bharadwaj A, Kim PY, Palaskas NL, Rashid M, Potts JE, Kwok CS, Gulati M, Zubaidi AB, Mamas M. P681 Acute Myocardial Infarction in patients with Leukaemia: A national analysis of prevalence, predictors and outcomes in United States hospitalisations (2004 to 2014). European Heart Journal 40(Suppl 1):ehz747.0287, 2019. e-Pub 2019.
      15. Borovac JA, Kwok CS, Konopleva M, Kim PY, Palaskas N, Zaman A, Butler R, Lopez-Mattei JC, Mamas MA. P676 Percutaneous coronary intervention and clinical outcomes in patients with lymphoma: a 10-year period United States nationwide inpatient sample (NIS) analysis. European Heart Journal 40(Suppl 1):ehz747.0282, 2019. e-Pub 2019.
      16. Tran P, Monlezum D, De Sirkar S, Iliescu G, Kim P, Lopez-Mattei J, Palaskas N, Durand JB, Iliescu C. Takotsubo cardiomyopathy preferentially impacts patients by primary malignancy type: multi-center nationally representative analysis of over 6 million hospitalizations. Journal of Cardiac Failure 25(8):S94, 2019. e-Pub 2019.
      17. Tran P, Monlezum D, De Sirkar S, Iliescu G, Kim P, Lopez-Mattei J, Palaskas N, Durand JB, Iliescu C. Takotsubo cardiomyopathy in HFrEF and thrombocytopenia: Multi-center machine learning supported analysis of mortality and costs among 6+ million hospitalizations. Journal of Cardiac Failure 25(8):S61, 2019. e-Pub 2019.
      18. Patnaik S, Armas L, Giza DE, Balanescu DV, Donisan T, Lopez-Mattei L Kim P, Kim P, Iliescu G, Thompason K, Mouhayar E, Daver N, Durand JB, Cortes J, Iliescu. Pulmonary Hypertension in Cancer Patients Treated with Tyrosine Kinase Inhibitors. Journal of Cardiac Failure 25(8):S149-S150, 2019. e-Pub 2019.
      19. Balanescu D, Donisan T, Monlezun D, Boone D, Cervoni Curet F, Balanescu S, Lee M, Palaskas N, Lopez-Mattei JC, Kim PY, Charitakis K, Marmagkiolis K, Iliescu C. A Case-Control Analysis of Coronary Angiography Findings and Cardiovascular Risk Factors of Cancer and Non-Cancer Patients. 2019 Scientific Sessions, 2019. e-Pub 2019.
      20. Gill C, Lee M, Canache A, Donisan T, Balanescu D, Raghunathan D, Song J, Palaskas N, Lopez-Mattei JC, Kim PY, Kar B, Gregoric I, Cilingiroglu M, Smalling R, Marmagkiolis K, Iliescu C. Transcatheter Aortic Valve Replacement is a Viable Option to Improve Mortality in Cancer Patients with Severe Aortic Stenosis Considered High Risk for Surgical Aortic Valve …. SCAI 2020 Scientific Sessions, 2019. e-Pub 2019.
      21. Zheng H, Morgan J, Chen C, Kaczmarek J, Ab K, Kim PY, Durand JB, Lopez-Mattei JC, Iliescu C, Palaskas N. Tissue is the issue! Immune checkpoint inhibitor myocarditis. SCAI 2020 Scientific Sessions, 2019. e-Pub 2019.
      22. Agha A, Gill C, Donisan T, Balanescu D, Lee M, Raghunathan D, Song J, Palaskas N, Lopez-Mattei JC, Kim PY, Durand JB, Cilingiroglu M, Marmagkiolis K, Iliescu C. The utility of thromboelastography (TEG) among cancer patients undergoing coronary angiography. SCAI 2020 Scientific Sessions, 2019. e-Pub 2019.
      23. Khan A, Zhang H, Chen C, Morgan J, Zarifa A, Shahid M, Song J, Naing A, Lopez-Mattei JC, Durand JB, Kim PY, Iliescu C, Palaskas N. Impact of pericardial effusion for patients receiving immune checkpoint inhibitors. 2020 Scientific Sessions, 2019. e-Pub 2019.
      24. Iliescu C, Balanescu D, Hassan S, Lopez-Mattei J, Palaskas N, Dasari A, Halperin D, Yao J, Kar B, Gregoric I, Nathan I, Durand JB, Karimzad K, Kim P, Iliescu G, Balanescu S, Marmagkiolis K, Donisan T. Predictors of mortality following cardiac surgery for carcinoid heart disease. Journal of Clinical Oncology 37(15 suppl):e15692-e15692, 2019. e-Pub 2019.
      25. Upadhyay A, Lopez-Mattei J, Kim P, Iliescu C, Durand JB, Palaskas N, Hassan S, Thompson K, Mouhayar E. Diagnostic performance of high sensitivity troponin in cancer patients. Journal of the American College of Cardiology 73(9S1):209-209, 2019. e-Pub 2019.
      26. McDermott L, Laeeq R, Palasks N, Moudgil R, Kim P, Yusuf S, Hassan S, Banchs J, Donisan T, Balanescu DV, Iliescu C, Durand JB, Lopez-Mattei J. Using Dobutamine Stress Echocardiography to Predict the Recovery of Left Ventricular Function in Cancer Patients Receiving Chemotherapy. Journal of the American College of Cardiology 73(9S1):1604, 2019. e-Pub 2019.
      27. Iliescu C, Balanescu D, Song J, Palaskas N, Karimzad K, Kim P, Lopez-Mattei J, Durand JB, Jipescu D, Gonzalez E, Ntim W, Balanescu S, Marmagkiolis K, Cilingiroglu M, Donisan T. Early Dual Antiplatelet Therapy Discontinuation in Cancer Patients with Newer Generation Drug-Eluting Stents: A Single Center Experience. Journal of the American College of Cardiology 73(9S1):1291-1291, 2019. e-Pub 2019.
      28. Agha A, Gill C, Balanescu D, Donisan T, Boone D, Song J, Iliescu G, Palaskas N, Lopez-Mattei J, Kim P, Doundoua D, Marmagkiolis K, Durand JB, Iliescu C. Coronary Angiography Among Cancer Patients: Determining a Safe Platelet Threshold. Journal of the American College of Cardiology 73(9S1):1289-1289, 2019. e-Pub 2019.
      29. Zarifa A, Kim P, Gilchrist S, Iliescu C, Suarez-Almazor ME, Lopez-Mattei J, Balanescu DV, Donisan T, Palaskas N, Upadhyay A, Moudgil R, Zhao B, Buja M, Durand JB. Expression of T-cell populations and molecular markers of human myocardium with checkpoint-induced myocarditis. Journal of Clinical Oncology 37(8 suppl):79, 2019. e-Pub 2019.
      30. Lee M, Dayah T, Balanescu D, Donisan T, Karimazad K Hakeem A, Boone D, Palaskas N, Lopez-Mattei J, Kim P, Durand JB, Song J, Balanescu SM, Yang EH, Herrmann J, Marmagkioli K, Toutouzas K, Johnson N, Iliescu C. 100.56 Reclassification of Treatment Strategy With Fractional Flow Reserve in Cancer Patients With Coronary Artery Disease. JACC: Cardiovascular Interventions 12(4S):S17-S18, 2019. e-Pub 2019.
      31. Donisan T, Balanescu D, Sudasena D, Dayah T, Giza D, Rodriguez De Armas L, Agarwal M, Iliescu G, Palaskas N, Lopez-Mattei J, Kim P, Durand JB, Cortes J, Iliescu. Echocardiographic Assessment of Cardiotoxicity in Chronic Myelogenous Leukemia Patients Receiving Dasatinib or Nilotinib. Circulation 138(Suppl 1):A11235-A11235, 2018. e-Pub 2018.
      32. Lopez-Mattei J, Verstovsek S, Iliescu C, Bhatti K, Palaskas N, Kim P, Gray B, Saadia F. Effect of Pulmonary Hypertension and Other Cardiovascular Diseases in Overall Prognosis of Patients with Myelofibrosis. Blood 132(Suppl 1):4310-4310, 2018. e-Pub 2018.
      33. Boone D, Monlezun D, Cervoni-Curet F, Chohan J, Sunny J, Bhatti K, Balanescu D, Donisan T, Iliescu G, Palaskas N, Lopez-Mattei J, Hassan S, Kim P, Durand JB, Balanescu S, Marmagkiolis K, Gonzalez E, Okwuosa T, Iliescu C. Malignancy Type Impacts Coronary Lesion Severity and Location: Multivariable Regression With Concurrent Machine Learning-Backed Case-Control Analysis. Circulation 138(Suppl 1):A16512-A16512, 2018. e-Pub 2018.
      34. Balanescu D, Donisan T, Schechter M, Dayah T, Sudasena D, Kar B, Gregoric I, Giza D, Stone J, Stone D, Boone D, Lopez-Mattei J, Kim P, Yusuf S, Cilingiroglu M, Toutouzas K, Boccalandro F, Smalling F, Marmagkiolis K, Iliescu C. TCT-609 Choosing Between Transcatheter, Surgical, and Medical Management in Cancer Patients With Severe Aortic Stenosis. Journal of the American College of Cardiology 72(13S):B244-B244, 2018. e-Pub 2018.
      35. Boone D, Monlezun D, Cervoni-Curet F, Chohan J, Sunny J, Bhatti K, Iliescu G, Balanescu D, Donisan T, Palaskas N, Lopez-Mattei J, Hassan S, Kim P, Marmagkiolis K, Iliescu C. TCT-150 Cardiovascular disease and percutaneous coronary intervention in hematological malignancies: knowledge is power. Journal of the American College of Cardiology 72(13S):B64-B64, 2018. e-Pub 2018.
      36. Balanescu DV, Liu VY, Donisan T, Agha AM, Lopez-Mattei JC, Giza DE, Iliescu G, Palaskas N, Kim PY, Boone DL, Yang EH, Herrmann J, Marmagkiolis K, Angelini P, Iliescu C. P1253 Clinical features and outcomes of patients with chemotherapy-induced Takotsubo stress cardiomyopathy. European Heart Journal 39(Suppl 1):ehy565. P1253, 2018. e-Pub 2018.
      37. Balanescu DV, Donisan T, Agha A, Dayah T, Lopez-Mattei J, Kim P, Durand JB, Iliescu C. Cardiomyopathy in Cancer Patients with Chronic Thrombocytopenia: To Cath or not to Cath?. Journal of Cardiac Failure 24(8):S44, 2018. e-Pub 2018.
      38. Donisan T, Dayah T, Balanescu DV, Karimzad K, Boone DL, Lopez-Mattei J, Kim PY, Durand JB, Yang EH, Herrmann J, Marmagkiolis K, Johnson NP, Iliescu C. Clinical outcomes after fractional flow reserve-guided treatment of oncology patients. Journal of Clinical Oncology 36(15 suppl):e22106-e22106, 2018. e-Pub 2018.
      39. Gurguis C, Armas L, Kantarjian H, Boddu PC, Jain P, Borthakur G, Giza D, Iliescu G, Lopez-Mattei J, Kim P, Garcia-Manero G, Ravandi F, Wierda W, Kornblau S, Jabbour E, Iliescu C, Cortes J. Echocardiographic Findings in Patients (pts) Receiving Tyrosine Kinase Inhibitors (TKIs) for the Treatment of Chronic Myeloid Leukemia (CML). Blood 130(Supplement 1):2893-2893, 2017. e-Pub 2017.
      40. Shumway J, Mouhayar M, Vickers H, Kim P, Rosenthal D, Mohamed A, Fuller C, Mouhayar E. Reproducibility and Precision of The Carotid Intima Media Thickness and Carotid Vascular Strain Measurements in Head and Neck Cancer Patients Undergoing Radiation Therapy. Vascular Medicine 22(3):270-270, 2017. e-Pub 2017.
      41. Giza D, Lopez-Mattei J, Kim P, Gonzalez E, Hermann J, Iliescu G, Yang E, Hassan S, Iliescu C. Stress Induced Cardiomyopathy Triggered By Chemotherapy: When Should Cancer Therapy Be Restarted?. Journal of the American College of Cardiology 69(11S):748-748, 2017. e-Pub 2017.
      42. Vejpongsa P, Kitkungvan D, Kim P. QT Interval and Cardiac Events in Cancer Patients: An Analysis of MD Anderson ECG Database from 2009-2012. Journal of the American College of Cardiology 63(12S):A283-A283, 2014. e-Pub 2014.
      43. Iliescu C, LeBeau T, Silva G, Frusina S, Agarwal M, Iliescu G, Tomakin G, Manoukian G, Banchs J, Kim P, Hassan S, Durand JB. Optical coherence tomography-guided antiplatelet therapy in patients with coronary artery disease and cancer: the PROTECT-OCT registry. Journal of the American College of Cardiology 61(10S):E1128-E1128, 2013. e-Pub 2013.
      44. Warner M, Faiz S, Koenig K, Middleton L, Kim P, Mouhayar E, Patel B, Bashoura L. Orthodeoxia Confounding a Diagnosis of Acute, Severe Pulmonary Hypertension With Metastatic Breast Cancer. Chest, 2011. e-Pub 2011.

      Book Chapters

      1. Kim PY, Cha J, Zarifa A, Salih M, Karimzad K. Oncologic Critical Care. In: Oncologic Critical Care. Springer, Cham, 2026.
      2. Mouhayar E, El-Haddad D, Kim P, Thompson K. The MD Anderson Manual of Medical Oncology 4th Edition. In: Oncocardiology In: The MD Anderson Manual of Medical Oncology 4th Edition. 4, 2022.
      3. Zarifa, A, Lopez-Mattei, J, Palaskas, NL, Iliescu, C, Durand, J, Kim, P. Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity, 377-387, 2021.
      4. Zarifa A, Lopez-Mattei J, Palaskas N, Iliescu C, Durand JB, Kim P. Immune Checkpoint Inhibitor related cardiotoxicity. In: Immunotherapy 4th Edition. 2021, 2021.
      5. Kim P, Zarifa A, Salih M, Karimzad K. Arrhythmias in Cancer Patients. In: Oncologic Critical Care, 733-751, 2020.
      6. Kim, P, Zarifa, A, Salih, M, Karimzad, K. Arrhythmias in cancer patients, 733-751, 2019.
      7. Chaftari P, Mouhayar E, Iliescu C, Hassan S, Kim P, Manzullo E, Escalante C, Gonzalez CE, Yeung S. Cardiac Emergencies in Cancer Patients. In: Oncologic Emergencies, Ed(s). In: ISBN:978-1-4939-3188-0, 2016.
      8. Mouhayar E, El-Haddad D, Kim P, Thompson K. The MD Anderson Manual of Medical Oncology 3rd Edition. In: Medical Oncology 3rd Edition, 2016.
      9. Kim, P, Vejpongsa, P, Yeh, E. Cancer therapy-induced cardiomyopathy, 715-725, 2013.
      10. Kim P, Vejpongsa P, Yeh, E. Cancer Therapy-induced Cardiomyopathy. In: Essential Cardiology: Principles & Practice. 3. Springer New York, 715-725, 2013.
      11. Kim P. Chemotherapy Induced Cardiomyopathy. In: Cancer Rehabilitation Medicine Quick Reference Book. 1, 2013.
      12. Kim PY. Long QT and Torsades de Pointes. In: 5 Minute ICU Consults. Lippincott Williams & Wilkins, 2011.
      13. Mouhayar E, Kim PY, et al. Onco-Cardiology in MD Anderson Manual of Medical Oncology. IV.
      14. Kim P, et al. QT Monitoring in Cancer Patients.
      15. Mouhayar E, El-Haddad D, Kim P, Thompson K. The MD Anderson Manual of Medical Oncology 5th edition. In: Oncocardiology In: The MD Anderson Manual of Medical Oncology 5th Edition.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 21, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top